Pricing Log in Create free account

AngioDynamics, Inc. (ANGO) vs Anbio Biotechnology (NNNN)

AngioDynamics, Inc. and Anbio Biotechnology are both Medical Instruments & Supplies companies. AngioDynamics, Inc. and Anbio Biotechnology are of similar size ($516.6M and $496.7M). Across the 8 metrics below, Anbio Biotechnology leads on 7 and AngioDynamics, Inc. on 1.

Valuation

Metric ANGO NNNN Medical Instruments & Supplies median
P/E n/m — 30.28
P/S 1.51 — 2.49
P/B 2.99 n/m 2.34
Price to free cash flow n/m n/m 23.49
EV/EBITDA n/m n/m 14.87
EV/Sales 1.57 n/m 2.75
Earnings yield (6.68%) — 0.00%
Free cash flow yield (0.48%) 0.00% 0.59%

Profitability

Metric ANGO NNNN Medical Instruments & Supplies median
Gross margin 55.65% — 53.60%
Operating margin (11.24%) — 1.97%
Net margin (10.12%) — 0.00%
Free cash flow margin 0.44% 0.00% 2.36%
Return on equity (19.21%) 0.00% 0.00%
Return on assets (12.98%) 0.00% 0.00%
Return on invested capital (17.58%) 0.00% 0.13%

Growth

Metric ANGO NNNN Medical Instruments & Supplies median
Revenue growth (TTM) 8.20% — 8.97%
EPS growth (last fiscal year) (6.02%) 150.00% 6.51%
Revenue growth, 5-year CAGR 1.93% — 8.85%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANGO NNNN Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 2.40 344.45 2.47
Net debt to EBITDA 3.17 (2.06) 0.97

Dividend

Metric ANGO NNNN Medical Instruments & Supplies median
Dividend yield — — 1.02%
Payout ratio — — 0.27

Size

Metric ANGO NNNN Medical Instruments & Supplies median
Market cap 496.67m 516.57m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack